Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.21.1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 31, 2021
NET LOSS PER SHARE  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31, 

 

    

2021

    

2020

Warrants

 

16,450,946

 

9,268,352

Preferred shares as convertible into common stock

 

9,444,444

 

537,500

Stock options

 

1,392,964

 

884,464

Total potentially dilutive shares

 

27,288,354

 

10,690,316